Fawad Sabooh Zafar, MD | |
1000 73rd St Ste 17, West Des Moines, IA 50265-1321 | |
(515) 277-8900 | |
(515) 223-7361 |
Full Name | Fawad Sabooh Zafar |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 39 Years |
Location | 1000 73rd St Ste 17, West Des Moines, Iowa |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003818493 | NPI | - | NPPES |
1649223835 | Medicaid | IA | |
340014274 | Other | IA | RAILROAD MEDICARE |
1649223835 | Other | IA | WELLMARK BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 30827 (Iowa) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Audubon County Memorial Hospital | Audubon, IA | Hospital |
Wayne County Hospital | Corydon, IA | Hospital |
Mercyone Centerville Medical Center | Centerville, IA | Hospital |
Lucas County Health Center | Chariton, IA | Hospital |
Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
Entity Name | Dallas County Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1861416307 PECOS PAC ID: 9931094257 Enrollment ID: O20040217000157 |
News Archive
Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled and treated the first patient in its SHINE clinical study in Europe.
AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.
For modern implants and the growth of artificial tissue and organs, it is important to generate materials with characteristics that closely emulate nature.
Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
› Verified 5 days ago
Entity Name | Fawad S. Zafar Md Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649223835 PECOS PAC ID: 6204888332 Enrollment ID: O20050216000657 |
News Archive
Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled and treated the first patient in its SHINE clinical study in Europe.
AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.
For modern implants and the growth of artificial tissue and organs, it is important to generate materials with characteristics that closely emulate nature.
Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Fawad Sabooh Zafar, MD 1000 73rd St Ste 17, West Des Moines, IA 50265-1321 Ph: (515) 277-8900 | Fawad Sabooh Zafar, MD 1000 73rd St Ste 17, West Des Moines, IA 50265-1321 Ph: (515) 277-8900 |
News Archive
Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, enrolled and treated the first patient in its SHINE clinical study in Europe.
AVANIR Pharmaceuticals, Inc. today announced the presentation of detailed data, including safety and tolerability data from the open-label extension as well as cardiac safety data from the double-blind phase of the Phase III confirmatory STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of pseudobulbar affect (PBA). The data were presented in two posters at the American Academy of Neurology (AAN) Annual Meeting in Toronto, Canada.
For modern implants and the growth of artificial tissue and organs, it is important to generate materials with characteristics that closely emulate nature.
Biological agents may play an important role in maintaining remission in Crohn's disease, according to two new studies in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association Institute.
› Verified 5 days ago
Dr. Samuel J. Storch, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5950 University Ave Ste 341, West Des Moines, IA 50266 Phone: 515-875-9255 Fax: 515-875-9101 | |
Dr. Jonathan M Fialkov, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave, Ste 341, West Des Moines, IA 50266 Phone: 515-875-9800 Fax: 515-875-9802 | |
Anthony Avallone, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 5950 University Ave Ste 341, West Des Moines, IA 50266 Phone: 515-875-9800 | |
Dr. John Clark Bardole, M.D. Urology Medicare: Medicare Enrolled Practice Location: 5950 University Ave, Ste 341, West Des Moines, IA 50266 Phone: 515-875-9800 Fax: 515-875-9802 | |
John Cochran, MD Urology Medicare: Medicare Enrolled Practice Location: 5950 University Ave Ste 341, West Des Moines, IA 50266 Phone: 515-875-9800 Fax: 515-875-9804 |